OTC Pharmaceuticals - Eastern Asia

Eastern Asia

Revenue in the OTC Pharmaceuticals market amounts to US$46.21bn in 2024. The market is expected to grow annually by 5.16% (CAGR 2024-2029).
The market's largest segment is the segment Cold & Cough Remedies with a market volume of US$11.17bn in 2024.
In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
In relation to total population figures, per person revenues of US$28.27 are generated in 2024.
In the OTC Pharmaceuticals market, 26.9% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Market

Region

Region comparison

Currency

Analyst Opinion

The OTC Pharmaceuticals market in Eastern Asia is experiencing significant growth and development. Customer preferences in the OTC Pharmaceuticals market in Eastern Asia are driven by several factors.

Firstly, there is a growing trend of self-medication among consumers in the region. This is due to increased awareness about health and wellness, as well as the convenience and accessibility of OTC medicines. Consumers prefer to treat minor ailments and common health issues on their own, without the need for a doctor's prescription.

Additionally, the rising healthcare costs in the region have also contributed to the preference for OTC medicines as a cost-effective alternative. In terms of trends in the market, there is a strong demand for OTC medicines that target specific health concerns. For example, there is a growing market for OTC medicines that address digestive issues, such as indigestion and heartburn.

This can be attributed to changing dietary habits and an increase in gastrointestinal disorders among the population. Similarly, there is a rising demand for OTC medicines that target respiratory issues, such as cough and cold. This is driven by factors such as air pollution and changing weather patterns in the region.

Local special circumstances also play a role in the development of the OTC Pharmaceuticals market in Eastern Asia. For instance, in countries like China, there is a strong tradition of using herbal remedies for various health conditions. This has led to the development of a thriving market for traditional Chinese medicine (TCM) OTC products.

These products are often seen as a more natural and holistic approach to healthcare, and are popular among consumers who prefer traditional remedies over conventional medicines. Underlying macroeconomic factors also contribute to the growth of the OTC Pharmaceuticals market in Eastern Asia. The region has experienced rapid economic growth in recent years, leading to an increase in disposable income among consumers.

This has resulted in higher spending power and a greater willingness to invest in healthcare products, including OTC medicines. Additionally, the aging population in many Eastern Asian countries has also contributed to the growth of the OTC Pharmaceuticals market. As the elderly population increases, there is a greater demand for OTC medicines that cater to age-related health issues.

In conclusion, the OTC Pharmaceuticals market in Eastern Asia is driven by customer preferences for self-medication, the demand for OTC medicines targeting specific health concerns, local special circumstances such as the popularity of traditional remedies, and underlying macroeconomic factors such as economic growth and aging population. These factors contribute to the development and growth of the market in the region.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.